异可利定
| 中文名称 | 异可利定 |
|---|---|
| 中文同义词 | 右旋异紫堇定;异紫堇定碱,右旋异紫堇定;异紫堇定碱;盐酸异紫堇定;异紫堇碱;ARTABOTRIN|||S-ISOCORYDINE(+)|||异紫堇定|||LUTEANIN|||UZOKORIDIN|||(+)-ISOCORYNOLINE;异紫堇定碱/生物碱类;异可利定 |
| 英文名称 | ISOCORYDINE HYDROCHLORIDE |
| 英文同义词 | LUTEANINE;LUTEANINE HYDROCHLORIDE;1,2,10-trimethoxy-6a-alpha-aporphin-11-o;4h-dibenzo(de,g)quinolin-11-ol,5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methy;artabotrin;d-isocorydine;l-(+)-isocorydine;luteanin |
| CAS号 | 475-67-2 |
| 分子式 | C20H23NO4 |
| 分子量 | 341.4 |
| EINECS号 | |
| 相关类别 | 精细化工;小分子抑制剂,天然产物;植物提取物;小分子抑制剂;标准品;中药对照品;对照品-中药对照品;标准品 -中药标准品;生物碱;Inhibitors;Miscellaneous Natural Products;Alkaloids |
| Mol文件 | 475-67-2.mol |
| 结构式 | ![]() |
异可利定 性质
| 熔点 | 216-220 °C(lit.) |
|---|---|
| 比旋光度 | D20 +195° (chloroform) |
| 沸点 | 477.03°C (rough estimate) |
| 密度 | 1.2064 (rough estimate) |
| 折射率 | 1.5614 (estimate) |
| 溶解度 | 溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。 |
| 形态 | 水晶。 |
| 酸度系数(pKa) | 9.41±0.20(Predicted) |
| 颜色 | White to off-white |
| InChI | InChI=1S/C20H23NO4/c1-21-8-7-12-10-15(24-3)20(25-4)18-16(12)13(21)9-11-5-6-14(23-2)19(22)17(11)18/h5-6,10,13,22H,7-9H2,1-4H3/t13-/m0/s1 |
| InChIKey | QELDJEKNFOQJOY-ZDUSSCGKSA-N |
| SMILES | N1(C)[C@]2([H])C3=C(C(OC)=C(OC)C=C3CC1)C1=C(O)C(OC)=CC=C1C2 |
Isocorydine (0-400 ug/ml; 48 hours) show a significant decrease in the IC50 for ICD and DOX, the CI values are 0.605, 0.644, 0.804, and 0.707 respectively for Huh-7, Hep-G2, SNU-449 and SNU-387. Isocorydine (0-400 ug/ml; 48 hours) abrogates DOX-induced upregulation of mesenchymal markers and the downregulation of epithelial markers in human HCC cell lines.
Cell Viability Assay
| Cell Line: | Huh-7, Hep-G2 , SNU-387, SNU-449 cells |
| Concentration: | 0-400 ug/ml |
| Incubation Time: | 24 hours |
| Result: | Had a higher cytotoxicity in HCC cells in comparison to ICD or DOX alone. |
Western Blot Analysis
| Cell Line: | Huh-7, Hep-G2 , SNU-387, SNU-449 cells |
| Concentration: | |
| Incubation Time: | 24 hours |
| Result: | Downregulated protein levels of Claundin-1 and E-cadherin. |
Isocorydine (intraperitoneal injection; 0.4 mg/kg; every 2 days for 2 weeks) retards the tumor growth, but the combined treatment of Doxorubicin (DOX) or ICD significantly inhibits tumor growth.
| Animal Model: | Female nude mice |
| Dosage: | 0.4 mg/ml |
| Administration: | Injected intraperitoneally every 2 days for 2 weeks |
| Result: | Combined treatment of isocorydine and DOX showed a promising potential to eradicate HCC. |
安全信息
| WGK Germany | 3 |
|---|---|
| RTECS号 | CE1057950 |
| 毒性 | LD50 intraperitoneal in mouse: 104mg/kg |
